Search - tctmd.com

Displaying 61 - 80 of 102

Sort: Relevancy | Date

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

Aficamten Safe, Effective for Up to 6 months in Obstructive HCM: REDWOOD-HCM OLE

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

May 31, 2022

Lingering Symptoms After COVID-19 Tied to Heart, Lung, and Kidney Injury

News Daily News

Lingering Symptoms After COVID-19 Tied to Heart, Lung, and Kidney Injury

May 30, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

May 25, 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion

News Conference News SCAI 2022

Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion

May 19, 2022

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

News Conference News HRS 2022

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

May 05, 2022

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

News Conference News HRS 2022

Intensive BP Control May Stave Off LV Conduction Disease: SPRINT

May 02, 2022

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

Durable Left Ventricular Device Therapy in 2022

Presentation ARCH 2022

Durable Left Ventricular Device Therapy in 2022

Presenter: Justin Hartupee

April 23, 2022

Left Ventricular Remodeling & Device Therapy in HF

Presentation ARCH 2022

Left Ventricular Remodeling & Device Therapy in HF

Presenter: Justin Vader

April 23, 2022

Myocarditis in Unvaxxed Patients Hospitalized With COVID-19: New Insights

News Daily News

Myocarditis in Unvaxxed Patients Hospitalized With COVID-19: New Insights

April 13, 2022

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

News Conference News ACC 2022

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

April 11, 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

April 03, 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

Pericardial Effusion Signals Worse Prognosis in COVID-19 Inpatients

News Conference News ACC 2022

Pericardial Effusion Signals Worse Prognosis in COVID-19 Inpatients

March 29, 2022

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

Good Results For TAVI in Bicuspid Valves, But Questions Persist

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.